Survival rates for stage 3 lung cancer can vary between 13% to 36% depending on the subtype. Stage 3a lung cancer is often treated with surgery and medicines before or after surgery. Stage 3b and 3c ...
5-year survival rate of 82.6% and 73% reduction in overall risk of death (hazard ratio of 0.27) are the strongest Multikine efficacy results reported to date, reflecting results in patients who met ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results